11.12.2009 • News

Sanofi Completes Merial Stake Buy

Sanofi-Aventis has completed the acquisitions of a 50 % stake in animal health firm Merial from joint venture partner Merck & Co. for $4.0 billion in a deal that will be earnings enhancing from the first year. Merial will report to Hanspeter Spek, Sanofi said.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read